Fingerprint
Dive into the research topics of 'Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: A phase II AIDS malignancy consortium trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: A phase II AIDS malignancy consortium trial
Joseph A. Sparano, Jeannette Y. Lee, Joel Palefsky, David H. Henry, William Wachsman, Lakshmi Rajdev, David Aboulafia, Lee Ratner, Thomas J. Fitzgerald, Lisa Kachnic, Ronald Mitsuyasu
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Oncology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations